- Report
- June 2021
- 229 Pages
Europe
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- July 2020
- 125 Pages
Europe
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- April 2023
- 120 Pages
Global
From €4588EUR$4,750USD£3,926GBP
- Report
- April 2023
- 115 Pages
Global
From €4588EUR$4,750USD£3,926GBP
- Report
- August 2022
- 120 Pages
Global
From €4588EUR$4,750USD£3,926GBP
- Report
- July 2021
- 115 Pages
Global
From €4588EUR$4,750USD£3,926GBP
- Report
- May 2021
- 112 Pages
Global
From €4298EUR$4,450USD£3,678GBP
- Report
- April 2023
- 251 Pages
Global
From €3477EUR$3,600USD£2,975GBP
- Report
- September 2022
- 417 Pages
Global
From €3477EUR$3,600USD£2,975GBP
- Report
- June 2020
- 38 Pages
Global
From €1927EUR$1,995USD£1,649GBP
- Report
- October 2020
Global
From €4829EUR$5,000USD£4,132GBP
- Report
- January 2020
Japan, United States, ... Japan, United States, Europe, Global
From €3718EUR$3,850USD£3,182GBP
- Report
- September 2020
- 275 Pages
Global
From €5572EUR$5,769USD£4,768GBP
- Report
- September 2023
- 160 Pages
Global
From €2896EUR$2,999USD£2,479GBP
The Covid 19 Testing market within the Diagnostics industry is a rapidly growing sector. It is driven by the need to identify and diagnose the virus in order to contain its spread. Tests are used to detect the presence of the virus in individuals, and to monitor the progression of the disease. Tests are also used to identify those who have been exposed to the virus, and to assess the effectiveness of treatments.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Companies offer a range of tests, from rapid antigen tests to more complex molecular tests. These tests are used in a variety of settings, from hospitals to laboratories to home-based testing.
Some of the companies in the Covid 19 Testing market include Abbott, Becton Dickinson, Cepheid, Roche, Thermo Fisher Scientific, and Quidel. Show Less Read more